[go: up one dir, main page]

NO20035696D0 - Krystallinsk anti-cholinergikum, fremgangsmåte for fremstilling derav og anvendelse derav til fremstilling av et legemiddel - Google Patents

Krystallinsk anti-cholinergikum, fremgangsmåte for fremstilling derav og anvendelse derav til fremstilling av et legemiddel

Info

Publication number
NO20035696D0
NO20035696D0 NO20035696A NO20035696A NO20035696D0 NO 20035696 D0 NO20035696 D0 NO 20035696D0 NO 20035696 A NO20035696 A NO 20035696A NO 20035696 A NO20035696 A NO 20035696A NO 20035696 D0 NO20035696 D0 NO 20035696D0
Authority
NO
Norway
Prior art keywords
cholinergic
drug
manufacture
preparation
crystalline anti
Prior art date
Application number
NO20035696A
Other languages
English (en)
Other versions
NO334301B1 (no
Inventor
Ulrike Werthmann
Peter Sieger
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of NO20035696D0 publication Critical patent/NO20035696D0/no
Publication of NO334301B1 publication Critical patent/NO334301B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
NO20035696A 2001-06-22 2003-12-19 Vannfritt, krystallinsk tiotropiumbromid, fremgangsmåte for fremstilling derav, legemiddel derav og anvendelse derav for fremstilling av et legemiddel for behandling av sykdommer NO334301B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10129710 2001-06-22
DE10215436 2002-04-08
PCT/EP2002/006291 WO2003000265A1 (de) 2001-06-22 2002-06-08 Kristallines anticholinergikum, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels

Publications (2)

Publication Number Publication Date
NO20035696D0 true NO20035696D0 (no) 2003-12-19
NO334301B1 NO334301B1 (no) 2014-02-03

Family

ID=26009556

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035696A NO334301B1 (no) 2001-06-22 2003-12-19 Vannfritt, krystallinsk tiotropiumbromid, fremgangsmåte for fremstilling derav, legemiddel derav og anvendelse derav for fremstilling av et legemiddel for behandling av sykdommer

Country Status (37)

Country Link
EP (1) EP1401445B1 (no)
JP (1) JP2005504015A (no)
KR (2) KR100971616B1 (no)
CN (1) CN100586948C (no)
AR (1) AR037491A1 (no)
AT (1) ATE337006T1 (no)
AU (1) AU2002345016B2 (no)
BG (1) BG66303B1 (no)
BR (1) BR0210537A (no)
CA (1) CA2450961C (no)
CO (1) CO5550423A2 (no)
CY (1) CY1105223T1 (no)
CZ (1) CZ302786B6 (no)
DE (1) DE50207943D1 (no)
DK (1) DK1401445T3 (no)
EA (1) EA005813B1 (no)
EE (1) EE05316B1 (no)
EG (1) EG24851A (no)
ES (1) ES2271280T3 (no)
HR (1) HRP20031066B1 (no)
HU (1) HUP0400333A3 (no)
IL (2) IL159238A0 (no)
ME (1) ME00412B (no)
MX (1) MXPA03011718A (no)
MY (1) MY122779A (no)
NO (1) NO334301B1 (no)
NZ (1) NZ530690A (no)
PE (2) PE20081305A1 (no)
PL (1) PL208137B1 (no)
PT (1) PT1401445E (no)
RS (1) RS50441B (no)
SA (1) SA02230255B1 (no)
SI (1) SI1401445T1 (no)
SK (1) SK287262B6 (no)
TW (2) TW200617007A (no)
UY (1) UY27342A1 (no)
WO (1) WO2003000265A1 (no)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10212264A1 (de) 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
US7056916B2 (en) 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
US20050038004A1 (en) * 2003-07-31 2005-02-17 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
JP4553902B2 (ja) * 2003-11-03 2010-09-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗コリン作用を有する新規結晶性無水物
DE102004016179A1 (de) * 2004-03-30 2005-10-20 Boehringer Ingelheim Pharma Verbindungen zur Behandlung von proliferativen Prozessen
DK2422786T3 (da) 2004-04-22 2014-11-17 Boehringer Ingelheim Int Nye lægemiddelkombinationer til behandling af luftvejssygdomme
US7220742B2 (en) 2004-05-14 2007-05-22 Boehringer Ingelheim International Gmbh Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
DE102004024454A1 (de) 2004-05-14 2005-12-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Enantiomerenreine Betaagonisten, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
ES2322148T3 (es) 2004-08-11 2009-06-17 BOEHRINGER INGELHEIM PHARMA GMBH &amp; CO. KG Medicamentos que contienen anticolinergicos para el tratamiento en las vias urinarias.
US20060079544A1 (en) * 2004-08-13 2006-04-13 Boehringer Ingelheim International Gmbh Medicaments for the prevention or treatment of alveolar pneumonia comprising an anticholinergic
DE102004048389A1 (de) 2004-10-01 2006-04-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Modifizierung von Oberflächen von Laktose als Hilfsstoff zur Verwendung für Pulverinhalativa
CN101163706A (zh) 2005-04-21 2008-04-16 贝林格尔·英格海姆国际有限公司 用于治疗炎性疾病的二氢噻吩并嘧啶
KR20080007645A (ko) 2005-04-28 2008-01-22 베링거 인겔하임 인터내셔날 게엠베하 염증성 질환 치료용 신규 화합물
SI1881980T1 (sl) 2005-05-02 2012-12-31 Boehringer Ingelheim International Gmbh Nove kristalinične oblike tiotropijevega bromida
RU2007144531A (ru) * 2005-05-02 2009-06-10 БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) Новые кристаллические формы тиотропийбромида
DE102005030733A1 (de) 2005-07-01 2007-01-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
BRPI0614410A2 (pt) 2005-08-15 2011-03-29 Boehringer Ingelheim Int processo para preparação de betamiméticos
TWI396541B (zh) 2005-10-10 2013-05-21 Boehringer Ingelheim Int 用於治療呼吸疾病之新穎藥物組合
US7423146B2 (en) 2005-11-09 2008-09-09 Boehringer Ingelheim International Gmbh Process for the manufacturing of pharmaceutically active 3,1-benzoxazine-2-ones
BRPI0608427A2 (pt) 2005-12-19 2009-12-29 Sicor Inc novas formas de brometo de tiotrópio e processos para seu preparo
US9108962B2 (en) 2005-12-19 2015-08-18 Sicor, Inc. Forms of tiotropium bromide and processes for preparation thereof
CN100999521B (zh) * 2006-01-13 2010-12-08 江苏正大天晴药业股份有限公司 结晶性抗胆碱药噻托溴铵
EP1847543A1 (de) 2006-04-19 2007-10-24 Boehringer Ingelheim Pharma GmbH & Co. KG Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
DE502007006951D1 (de) 2006-08-07 2011-05-26 Boehringer Ingelheim Pharma Arzneimittelkombinationen zur behandlung von atemwegserkrankungen
UY30550A1 (es) 2006-08-22 2008-03-31 Boehringer Ingelheim Int Nuevos beta-agonistas enantioméricamente puros, procedimientos para su preparacion y su uso como medicamentos
GB0716026D0 (en) 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
BRPI0818006B8 (pt) 2007-10-19 2021-05-25 Boehringer Ingelheim Int compostos de piperidino-di-hidrotienopirimidinas substituídas, uso dos mesmos e formulações farmacêuticas
EP2093219A1 (de) 2008-02-22 2009-08-26 Boehringer Ingelheim International Gmbh Kristalline, enantiomerenreine Salzform eines Betamimetikums und dessen Verwendung als Arzneimittel
EA020548B1 (ru) 2008-12-19 2014-12-30 Бёрингер Ингельхайм Интернациональ Гмбх Циклические пиримидин-4-карбоксамиды в качестве антагонистов рецептора ccr2, предназначенные для лечения воспаления, астмы и хозл
EP2403851B1 (en) 2009-03-06 2015-06-17 Mahmut Bilgic New crystalline forms of tiotropium bromide
JP5658272B2 (ja) 2009-12-17 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｃｒ２の新規アンタゴニスト及びこれらの使用
ME01908B (me) 2009-12-17 2014-12-20 Boehringer Ingelheim Int Novi antagonisti ccr2 receptora i njihova primjena
KR20120125267A (ko) 2010-01-29 2012-11-14 베링거 인겔하임 인터내셔날 게엠베하 치환된 나프티리딘 및 ｓｙｋ 키나제 억제제로서의 이의 용도
WO2011141477A1 (en) 2010-05-12 2011-11-17 Boehringer Ingelheim International Gmbh New ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
US8877745B2 (en) 2010-05-12 2014-11-04 Boehringer Ingelheim International Gmbh CCR2 receptor antagonists, method for producing the same, and use thereof as medicaments
US8841313B2 (en) 2010-05-17 2014-09-23 Boehringer Ingelheim International Gmbh CCR2 antagonists and uses thereof
WO2011147772A1 (en) 2010-05-25 2011-12-01 Boehringer Ingelheim International Gmbh Ccr2 receptor antagonists
EP2576538B1 (en) 2010-06-01 2015-10-28 Boehringer Ingelheim International GmbH New CCR2 antagonists
TR201007108A2 (tr) * 2010-08-25 2012-03-21 B�Lg�� Mahmut Yeni tiotropyum bromür kristali ve üretim yöntemi.@
EP2668177B1 (en) 2011-01-28 2014-10-22 Boehringer Ingelheim International GmbH Substituted pyridinyl-pyrimidines and their use as medicaments
TR201101897A2 (tr) 2011-02-28 2012-09-21 Bi̇lgi̇ç Mahmut Tiotropyum bromür içeren kristal madde
TR201102068A2 (tr) 2011-03-03 2012-09-21 Bi̇lgi̇ç Mahmut Tiotropyum bromür içeren kristal maddeler
TR201111589A2 (tr) * 2011-03-03 2012-09-21 Bi̇lgi̇ç Mahmut Tiotropyum bromür susuz kristal formu.
JP5786257B2 (ja) 2011-06-16 2015-09-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規の選択的ｃｃｒ２拮抗薬
EP2731941B1 (en) 2011-07-15 2019-05-08 Boehringer Ingelheim International GmbH Novel and selective ccr2 antagonists
KR101986484B1 (ko) 2011-07-26 2019-06-10 베링거 인겔하임 인터내셔날 게엠베하 치환된 퀴놀린 및 이의 약제로서의 용도
US20130059866A1 (en) 2011-08-24 2013-03-07 Boehringer Ingelheim International Gmbh Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
PE20190180A1 (es) 2011-11-25 2019-02-01 Adverio Pharma Gmbh Procedimiento de preparacion de 5-fluoro-1h-pirazolopiridinas sustituidas
CZ304368B6 (cs) 2011-11-28 2014-04-02 Zentiva, K.S. Směsný solvát tiotropium bromidu a způsob jeho přípravy
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
PT106142B (pt) * 2012-02-10 2014-07-18 Hovione Farmaci Ncia S A Processo para a preparação de brometo de tiotrópio
US9096579B2 (en) 2012-04-20 2015-08-04 Boehringer Ingelheim International Gmbh Amino-indolyl-substituted imidazolyl-pyrimidines and their use as medicaments
EP2897955B1 (en) * 2012-09-11 2019-11-06 Bilgic, Mahmut New tiotropium bromide crystalline form
UA115888C2 (uk) 2012-11-05 2018-01-10 Зентіва, К.С. Стабілізація сольватів тіотропію
CN104341412A (zh) * 2013-07-29 2015-02-11 天津金耀集团有限公司 一种无水噻托溴铵结晶的制备方法
KR102431017B1 (ko) 2014-03-19 2022-08-11 베링거 인겔하임 인터내셔날 게엠베하 헤테로아릴 syk 억제제
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
PE20171344A1 (es) 2014-10-21 2017-09-13 Ariad Pharma Inc Formas cristalinas de 5-cloro-n4-[2-(dimetilfosforil)fenil]-n2-{2-metoxi-4-[4-(4-metilpiperazin-1-il)piperidin-1-il]pirimidina-2,4-diamina
EP3414243A1 (en) * 2016-02-11 2018-12-19 Sima Patent Ve Lisanslama Hizmetleri Ltd. STI Crystalline form of tiotropium bromide anhydrate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US5610163A (en) * 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
AP1572A (en) * 2000-10-12 2006-02-13 Boehringer Ingelheim Pharma Crystalline monohydrate, method for producing the same and use thereof in the production of a medicament.
DE10064816A1 (de) * 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums

Also Published As

Publication number Publication date
CZ302786B6 (cs) 2011-11-09
PT1401445E (pt) 2006-10-31
AU2002345016B2 (en) 2008-04-17
KR20040018285A (ko) 2004-03-02
CA2450961C (en) 2010-03-30
BG66303B1 (bg) 2013-03-29
TW200617007A (en) 2006-06-01
HRP20031066B1 (en) 2011-10-31
SK522004A3 (en) 2004-06-08
KR101011353B1 (ko) 2011-01-28
PL208137B1 (pl) 2011-03-31
SA02230255B1 (ar) 2006-10-31
BG108440A (bg) 2004-08-31
CN100586948C (zh) 2010-02-03
PE20030130A1 (es) 2003-04-02
DK1401445T3 (da) 2006-11-27
HK1068540A1 (zh) 2005-04-29
HUP0400333A2 (hu) 2004-12-28
DE50207943D1 (de) 2006-10-05
MEP62008A (en) 2011-05-10
BR0210537A (pt) 2004-06-22
CN1520294A (zh) 2004-08-11
MY122779A (en) 2006-05-31
EP1401445A1 (de) 2004-03-31
EA200301293A1 (ru) 2004-08-26
PE20081305A1 (es) 2008-10-01
SI1401445T1 (sl) 2007-02-28
MXPA03011718A (es) 2004-12-06
RS50441B (sr) 2010-03-02
CY1105223T1 (el) 2010-03-03
YU99703A (sh) 2006-05-25
UY27342A1 (es) 2003-02-28
CA2450961A1 (en) 2003-01-03
WO2003000265A1 (de) 2003-01-03
KR100971616B1 (ko) 2010-07-22
ES2271280T3 (es) 2007-04-16
EE200400029A (et) 2004-04-15
IL159238A (en) 2010-04-15
EE05316B1 (et) 2010-08-16
HRP20031066A2 (en) 2004-04-30
NZ530690A (en) 2005-05-27
KR20090031638A (ko) 2009-03-26
CO5550423A2 (es) 2005-08-31
CZ2004120A3 (cs) 2004-05-12
TWI261589B (en) 2006-09-11
HUP0400333A3 (en) 2012-10-29
NO334301B1 (no) 2014-02-03
EP1401445B1 (de) 2006-08-23
ATE337006T1 (de) 2006-09-15
AR037491A1 (es) 2004-11-17
IL159238A0 (en) 2004-06-01
SK287262B6 (sk) 2010-04-07
PL364489A1 (en) 2004-12-13
JP2005504015A (ja) 2005-02-10
ME00412B (me) 2011-10-10
EG24851A (en) 2010-10-27
EA005813B1 (ru) 2005-06-30

Similar Documents

Publication Publication Date Title
NO20035696D0 (no) Krystallinsk anti-cholinergikum, fremgangsmåte for fremstilling derav og anvendelse derav til fremstilling av et legemiddel
NO20031694L (no) Krystallinsk monohydrat, fremgangsmåte for fremstilling derav og anvendelsederav til fremstilling av et medikament
DK1144386T3 (da) Polymorf form af telmisartan, fremgangsmåde til fremstilling deraf og anvendelse deraf til fremstilling af et lægemiddel
AU2002345016A1 (en) Crystalline anticholinergic, method for its production, and use thereof in the production of a drug
NO20015156D0 (no) 5-pyridyl-1,3-Azol forbindelser, fremgangsmåte for produksjon av de samme og deres anvendelse
TWI345975B (en) Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
IL191926A0 (en) Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof
DK1345910T3 (da) Quinazolinderivater, lægemidler indeholdende forbindelserne, deres anvendelse og fremgangsmåde til fremstilling deraf
NO20035496D0 (no) Substituerte sulfonamidforbindelser, fremgangsmåte for deres anvendelse sommedikament til behandling av CNS-forstyrrelser, overvekt og typeII-diabetes
NO20043000L (no) Et preparat for behandling av nevrocerebrovaskulaere sykdommer
DK1381605T3 (da) Mercaptoacetylamidderivater, en fremgangsmåde til deres fremstilling og deres anvendelse
NO20024623L (no) Ny fremgangsmÕte for fremstilling av kondensert imidazopyridinderivat og ny krystallform
DK1482780T3 (da) Fremgangsmåde til fremstilling af et mælkeprodukt
EE200300537A (et) Meetod madalaannuselise farmatseutilise kompositsiooni tootmiseks
IS7153A (is) Aðferð til framleiðslu á 14-hýdroxýnormorfínon afleiðu
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
DK1399424T3 (da) Fremgangsmåde til fremstilling af 10,11-dihydro-10-hydroxy-5H-dibenz[b,f]azepin-5-carboxamid og 10,11-dihydro-10-oxo-5H-dibenz[b,f]azepin-5-carboxamid
WO2002060906A3 (en) Crystal modification of olanzapine
NO20031413L (no) Ny fremgangsmate for fremstilling av oksabispidiner og nytt mellomprodukt
NO20053368D0 (no) Fremgangsmate for fremstilling av en farmasoytisk ren polymorf I av olanzapin.
NO20044332L (no) Forbedret fremgangsmate for fremstilling av nevirapine
NO331169B1 (no) Krystallinsk form av et fenyletanolamin, fremstilling derav og farmasoytisk preparat og legemiddel omfattende den samme
NO20040485L (no) Fremgangsmåte til fremstilling av amorf form av torsemid.
HUP0401921A3 (en) Intermediate compounds for the preparation of mirtazapine and the production methods thereof
IS7846A (is) Aðferð til að framleiða lyfjafræðilega virkt efnasamband og til að framleiða milliefni þess

Legal Events

Date Code Title Description
MK1K Patent expired